University Clinical Hospital of Salamanca

Salamanca 37007

2 studies enrolling now · 3 studies all time

What they study most

MF, Myelofibrosis, Post-ET Myelofibrosis, Post-PV MF, Primary Myelofibrosis, SCC - Squamous Cell Carcinoma of Skin, VEXAS, VEXAS Syndrome

Studies at this site

• A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS) — Recruiting now
• Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib — Recruiting now
• Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC. — Stopped early